Search Results 751-760 of 21342 for anti-TNF drugs

1. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

   Use of anti-inflammatory medications listed below within the last 30 days: Leflunomide; Sulfasalazine; Mycophenolate; Cyclosporine; Cyclophosphamide ...

2. Umbralisib (Oral Route) Description and Brand Names - Mayo Clinic

   ... treatment (refractory) in patients who have received at least one previous treatment (eg, anti-CD20-based treatment). It is also used to treat follicular ...

3. Intensity-modulated radiation therapy (IMRT) - Mayo Clinic

   Learn how technology allows specialists to precisely manipulate radiation therapy beams so that they conform to the shape of a tumor and avoid healthy ...

4. Reducing post-polypectomy bleeding events in patients who require antithrombotic agents - Mayo Clinic

   When temporarily discontinuing the use of thienopyridine anti-platelet agents, Dr. Abraham emphasizes that the duration of the interruption depends on the half- ...

5. Lovotibeglogene Autotemcel (Intravenous Route) Description and Brand Names - Mayo Clinic

   Lovotibeglogene autotemcel injection is a one-time gene therapy used to treat sickle cell disease (red blood cell disease) in patients who have a history of ...

6. Imiquimod (Topical Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aldara; Zyclara. Descriptions. Imiquimod ...

7. Trimethoprim (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Primsol; Proloprim; Trimpex. Descriptions.

8. Myelofibrosis - Diagnosis and treatment - Mayo Clinic

   Thalidomide (Thalomid) and the related drug lenalidomide (Revlimid) may help improve blood cell counts and may also relieve an enlarged spleen. These drugs may ...

9. Daunorubicin (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Targeting VEGF-Independent Proangiogenic Pathways in Anti-VEGF Refractory Renal Cell Cancer - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    Mukhopadhyay's lab is developing novel treatment strategies to target these pathways for refractory and highly aggressive tumor types and for sarcomatoid renal ...